AU2006271653A1 - Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes - Google Patents

Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes Download PDF

Info

Publication number
AU2006271653A1
AU2006271653A1 AU2006271653A AU2006271653A AU2006271653A1 AU 2006271653 A1 AU2006271653 A1 AU 2006271653A1 AU 2006271653 A AU2006271653 A AU 2006271653A AU 2006271653 A AU2006271653 A AU 2006271653A AU 2006271653 A1 AU2006271653 A1 AU 2006271653A1
Authority
AU
Australia
Prior art keywords
formula
alkyl
denotes
methyl
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006271653A
Other languages
English (en)
Inventor
Waldemar Pfrengle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Boehringer Ingelheim International GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International GmbH filed Critical Boehringer Ingelheim International GmbH
Publication of AU2006271653A1 publication Critical patent/AU2006271653A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Saccharide Compounds (AREA)
AU2006271653A 2005-07-22 2006-07-20 Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes Abandoned AU2006271653A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05015935 2005-07-22
EP05015935.9 2005-07-22
PCT/EP2006/064435 WO2007010015A1 (en) 2005-07-22 2006-07-20 Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes

Publications (1)

Publication Number Publication Date
AU2006271653A1 true AU2006271653A1 (en) 2007-01-25

Family

ID=37102155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006271653A Abandoned AU2006271653A1 (en) 2005-07-22 2006-07-20 Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes

Country Status (14)

Country Link
EP (1) EP1910391A1 (ja)
JP (2) JP4888840B2 (ja)
KR (1) KR20080036112A (ja)
CN (1) CN101218244A (ja)
AR (1) AR054852A1 (ja)
AU (1) AU2006271653A1 (ja)
BR (1) BRPI0613690A2 (ja)
CA (1) CA2621269A1 (ja)
IL (1) IL188898A0 (ja)
MX (1) MX2008000011A (ja)
RU (1) RU2008106461A (ja)
TW (1) TW200728286A (ja)
WO (1) WO2007010015A1 (ja)
ZA (1) ZA200709951B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2500873C (en) * 2002-10-04 2012-01-17 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
US7375090B2 (en) 2003-08-26 2008-05-20 Boehringer Ingelheim International Gmbh Glucopyranosyloxy-pyrazoles, pharmaceutical compositions containing these compounds, the use thereof and processed for the preparation thereof
UY29694A1 (es) * 2005-07-28 2007-02-28 Boehringer Ingelheim Int Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido
UY30082A1 (es) 2006-01-11 2007-08-31 Boehringer Ingelheim Int Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
JP5902671B2 (ja) * 2011-03-31 2016-04-13 キッセイ薬品工業株式会社 ベンジルピラゾール誘導体の製造方法およびその製造中間体

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55157504A (en) * 1979-05-24 1980-12-08 Sankyo Co Ltd Herbicide
DE60141156D1 (de) * 2000-11-02 2010-03-11 Ajinomoto Kk Neue pyrazolderivate und diese enthaltende mittel gegen diabetes
EP1354888B1 (en) * 2000-12-28 2009-05-20 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxypyrazole derivatives and use thereof in medicines
CA2438593C (en) * 2001-02-26 2010-09-21 Kissei Pharmaceutical Co., Ltd. Glucopyranosyloxypyrazole derivatives and medicinal use thereof
ES2350084T3 (es) * 2001-02-27 2011-01-18 Kissei Pharmaceutical Co., Ltd. Derivados de glucopiranosiloxipirazol y uso médico de los mismos.
CA2445346C (en) * 2001-04-27 2010-04-06 Ajinomoto Co., Inc. N-substituted pyrazole-o-glycoside derivatives and therapeutic agent for diabetes containing the same
EP1400529A4 (en) * 2001-05-30 2007-12-19 Kissei Pharmaceutical GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
WO2003020737A1 (en) * 2001-09-05 2003-03-13 Bristol-Myers Squibb Company O-pyrazole glucoside sglt2 inhibitors and method of use
CA2484306A1 (en) * 2002-04-26 2003-11-06 Katsumi Maezono Prophylactic and therapeutic agent of diabetes mellitus
DE60332743D1 (de) * 2002-08-08 2010-07-08 Kissei Pharmaceutical Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
JP2004137245A (ja) * 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
JP4606876B2 (ja) * 2002-08-27 2011-01-05 キッセイ薬品工業株式会社 ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途
CA2500873C (en) * 2002-10-04 2012-01-17 Kissei Pharmaceutical Co., Ltd. Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
EP1609799A4 (en) * 2003-04-01 2008-10-29 Taisho Pharmaceutical Co Ltd HETEROARYL-5-THIO-BETA-D-GLUCOPYRANOSIDE DERIVATIVES AND AGENTS AGAINST DIABETES THEREOF
WO2004113359A1 (ja) * 2003-06-20 2004-12-29 Kissei Pharmaceutical Co., Ltd. ピラゾール誘導体、それを含有する医薬組成物及びその製造中間体
UY29694A1 (es) * 2005-07-28 2007-02-28 Boehringer Ingelheim Int Metodos para prevenir y tratar trastornos metabolicos y nuevos derivados de pirazol-o-glucosido

Also Published As

Publication number Publication date
IL188898A0 (en) 2008-04-13
AR054852A1 (es) 2007-07-18
CN101218244A (zh) 2008-07-09
TW200728286A (en) 2007-08-01
WO2007010015A1 (en) 2007-01-25
ZA200709951B (en) 2008-11-26
BRPI0613690A2 (pt) 2011-01-25
JP2009502763A (ja) 2009-01-29
MX2008000011A (es) 2008-03-26
JP4888840B2 (ja) 2012-02-29
RU2008106461A (ru) 2009-08-27
KR20080036112A (ko) 2008-04-24
JP2012006956A (ja) 2012-01-12
EP1910391A1 (en) 2008-04-16
CA2621269A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
NO340420B1 (no) Metode for fremstilling av 1-(3-(2-(1-benzotiofen-5-yl)-etoksy)propyl)azetidin-3-ol eller salter derav
AU2010247212B2 (en) 5-membered heterocyclic compound cyclopenta[c]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof
TWI679204B (zh) 苯并惡唑并惡嗪酮類化合物的製備方法及其中間體和晶型
AU2006271653A1 (en) Processes for preparing pyrazole-o-glycoside derivatives and novel intermediates of said processes
TW200531958A (en) Method for producing aminophenol compounds
NO317258B1 (no) Fremgangsmate til fremstilling av et beskyttet 4-aminometyl-pyrrolidin-3-on
UA56269C2 (uk) Спосіб одержання похідних тіазолідиндіону
JPWO2004106352A1 (ja) アルドヘキソピラノース中間体の製造法
CA3042923A1 (en) A simple process for preparing avibactam
WO2015018289A1 (zh) 一种合成阿哌沙班重要中间体的新方法
CN110612291B (zh) 2-([1,2,3]三唑-2-基)-苯甲酸衍生物的制备
EP1764365A1 (en) A process for the preparation of sartan derivates and intermediates useful in such process
US20080020987A1 (en) Processes for preparing pyrazole-O-glycoside derivatives and novel intermediates of said processes
EP0916656B1 (en) A method for production of pyrrolidinone derivatives
EP4153599B1 (en) Process for manufacturing alkyl 7-amino-5-methyl-[1,2,5]oxadiazolo[3,4-b]pyridine-carboxylate
KR101299720B1 (ko) 3-아미노-5-플루오로-4-디알콕시펜탄산 에스테르의 새로운제조방법
WO2010087770A1 (en) Novel process for preparing carboxy-containing pyrazoleamido compounds 597
CA3214107A1 (en) New process for the synthesis of 5-{5-chloro-2-[(3s)-3- [(morpholin-4-yl)methyl]-3,4-dihydroisoquinoline-2(1h)- carbonyl]phenyl}-1,2-dimethyl-1h-pyrrole-3-carboxylic acid derivatives and its application for the production of pharmaceutical compounds
Tomer IV et al. Synthesis of the novel thieno [4, 3, 2‐ef][1, 4] benzoxazepine ring system: 4, 5‐Dihydro‐3‐(4‐pyridinyl) thieno [4, 3, 2‐ef][1, 4] benzox‐azepine maleate
JPWO2006083010A1 (ja) ４−アセチルピリミジン化合物の製造方法およびその結晶
CN115785089A (zh) 一种利奥西呱杂质c的合成方法
HUT52052A (en) Process for producing 4-ethinyl-4-/2-amino-phenoxy/-piperidine derivatives and acid additional salts
Liu et al. Improved preparation of C-aryl glucoside SGLT2 inhibitors
WO2007052001A2 (en) Production process of ortho-substituted benzoic acid derivatives usin 4-(2-carboxybenzyloxy or thio)-phenylacetic acid as key intermediate

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period